Advanced Drug Delivery Systems Market Forecast Signals New Revenue Opportunities Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The advanced drug delivery systems sector is experiencing robust development, driven by multiple factors shaping healthcare and pharmaceutical innovation. As medical needs evolve and new technologies emerge, this market is set to expand significantly over the coming years. Below is an in-depth look at the market’s size, growth drivers, key players, trends, and regional dynamics.
Advanced Drug Delivery Systems Market Size and Growth Forecast
The advanced drug delivery systems market has demonstrated strong growth in recent years. It is projected to increase from $285.59 billion in 2025 to $310.15 billion in 2026, growing at a compound annual growth rate (CAGR) of 8.6%. This historical growth stems from several key factors including the expansion of pharmaceutical research and development, a rising number of chronic disease cases, breakthroughs in formulation science, increased use of injectable drug therapies, and a heightened emphasis on improving treatment efficacy.
Looking ahead, the market is expected to maintain its upward trajectory, reaching $433.56 billion by 2030 with a CAGR of 8.7%. Continued growth will be driven by rising demand for personalized medicines, greater adoption of biologic drugs, advancements in nanotechnology-based therapies, enhanced efforts to reduce side effects, and increased investments in sophisticated drug delivery platforms. Emerging trends likely to influence this market include wider use of targeted drug delivery technologies, nanocarrier-based formulations, controlled release systems, and expansion of delivery options for biologics and biosimilars, all emphasizing patient-centered approaches.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12683&type=smp
Important Factors Propelling Growth in the Advanced Drug Delivery Systems Market
One of the primary factors fueling growth is the increasing prevalence of chronic diseases worldwide. These long-lasting conditions, which require ongoing medical care and often limit daily activities, are linked to risk behaviors such as tobacco use, poor nutrition, lack of exercise, and excessive alcohol consumption. Advanced drug delivery systems play a crucial role by enabling targeted delivery of medications to specific affected areas, improving therapeutic effectiveness while minimizing side effects.
For example, data from May 2023 by The United Nations highlights that chronic diseases account for seven out of 10 deaths in the United States, claiming over 1.7 million lives annually. This significant health burden underscores the urgent need for innovative drug delivery solutions, making the growing prevalence of chronic illnesses a key driver behind market expansion.
Overview of Market Segments and Their Growth Potential in Advanced Drug Delivery Systems
This market is divided into multiple segments that cover a broad spectrum of technologies and applications:
– By Type: Oral drug delivery systems, injection-based systems, inhalation or pulmonary systems, transdermal systems, transmucosal systems, carrier-based systems, and other types.
– By Carrier Type: Liposomes, nanoparticles, microspheres, and other carriers.
– By Technology: Prodrugs, implants and intrauterine devices, targeted delivery, polymeric delivery systems, and other technologies.
– By Application Area: Cardiovascular diseases, oncology, urology, diabetes, central nervous system disorders, ophthalmology, inflammatory diseases, infections, and additional applications.
– By End User: Hospitals, specialized clinics, and clinical research and development centers.
Further subcategories include oral delivery forms such as solid, liquid, and novel oral systems; injection methods like autoinjectors and microneedle-based devices; inhalation devices including metered-dose inhalers, dry powder inhalers, nebulizers, and soft mist inhalers; transdermal forms such as patches and iontophoresis; transmucosal systems covering buccal, sublingual, and nasal routes; carrier-based systems like dendrimers and niosomes; and other specialized types such as implantable devices and bioadhesive systems.
Advanced Drug Delivery Systems Market Regional Analysis: Which Region Leads By Revenue?
Current Trends Impacting Expansion in the Advanced Drug Delivery Systems Market
Key players in this market are investing heavily in innovative technologies to meet the increasing demand for convenient and patient-friendly treatments. One notable advancement is in subcutaneous biologic delivery, which offers a less invasive alternative to traditional intravenous infusions and allows for rapid administration of high drug volumes under the skin.
For example, in June 2023, US-based biopharmaceutical company Halozyme Therapeutics received FDA approval for VYVGART Hytrulo with ENHANZE, a novel subcutaneous formulation designed for generalized myasthenia gravis. This treatment combines efgartigimod alfa with Halozyme’s recombinant human hyaluronidase PH20 (rHuPH20), enabling fast, high-volume delivery through a single injection. It significantly reduces infusion time, enhances patient convenience, supports home-based treatment, and maintains clinical efficacy similar to intravenous administration.
Key Companies Shaping the Advanced Drug Delivery Systems Market
Several major corporations lead the advanced drug delivery systems market, including:
Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, and Insulet Corporation.
Regional Market Insights and Growth Patterns for Advanced Drug Delivery Systems
In 2025, North America led the advanced drug delivery systems market in terms of revenue. However, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period. The market analysis encompasses regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of the global market landscape.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
